Senti Biosciences is a Bay Area biotech company focused on outsmarting complex diseases with more intelligent medicines.

Senti Biosciences leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2016

• LUX Partners

  • Adam Goulburn

• Latest Tweets

  • #News: We’re collaborating with @spark_tx to apply our #genecircuit technology to development of next-gen #gene the… https://t.co/R6b8Ny9jxa@SentiBio - 12:36 PM Apr 13th
  • #News: Our preclinical POC data @AACR shows that Logic Gating #genecircuits can program #NKcells to recognize cance… https://t.co/an4GjV6lOl@SentiBio - 12:54 PM Apr 12th
  • We're presenting at @ISBioTech's #10thSpringMeetingRedux on March 17th at 2:20pm ET on the development of a GMP rel… https://t.co/ksG6LcgZyw@SentiBio - 07:47 PM Mar 15th